CBRE

AI Research

CBRE Faces Share Price Weakness → UBS Upgrades to Buy $185, Barclays Cuts to $174 Overweight

CBRE Group faces diverging analyst views as UBS upgraded the stock to Buy with a $185 price target while Barclays reduced its target to $174 but maintained Overweight, with the average analyst price target of $179.86 reflecting moderate upside from current levels. The commercial real estate services giant benefits from its global transaction advisory and property management scale as deal volumes gradually recover. Risks include persistent commercial real estate transaction volume weakness, office market structural headwinds from remote work, and potential credit losses in the real estate investment management segment.